HomeInsightsPE

Orchid Pharma Ltd PE Ratio

Orchid Pharma Ltd PE Ratio

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

1.8 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Orchid Pharma Ltd

NSE: ORCHPHARMA

PE

73.5

Last updated on: Dec 11, 2024

Key Highlights

  • The P/E Ratio of Orchid Pharma Ltd is 73.5 as of 11 Dec 15:30 PM .
  • The P/E Ratio of Orchid Pharma Ltd changed from 0.7 on March 2019 to 57.5 on March 2024 . This represents a CAGR of 108.49% over 6 years.
  • The Latest Trading Price of Orchid Pharma Ltd is ₹ 1733 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Orchid Pharma Ltd

No data available

Company Fundamentals for Orchid Pharma Ltd

No data available

Image

Orchid Pharma Ltd

NSE: ORCHPHARMA

Share Price

₹ 1733.25

8.85 (0.51%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Orchid Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Orchid Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Dec 20241724.4
09 Dec 20241755.9
06 Dec 20241753.9
05 Dec 20241699.5
04 Dec 20241697.9
03 Dec 20241683.15
02 Dec 20241725.2
29 Nov 20241674.8
28 Nov 20241626
27 Nov 20241575.35

SWOT Analysis Of Orchid Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Orchid Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Orchid Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Orchid Pharma Ltd738,746
Sun Pharmaceuticals Industries Ltd384,34,148
Divis Laboratories Ltd851,57,464
Cipla Ltd251,17,560
Torrent Pharmaceuticals Ltd651,13,318
Mankind Pharma Ltd501,06,927

Key Valuation Metric of Orchid Pharma Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Orchid Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Orchid Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payout of Orchid Pharma Ltd

No data available

* All values are in %

About Orchid Pharma Ltd

  • Orchid Pharma Limited, is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries.
  • Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
  • The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products.
  • Antibiotics are life-saving drugs used to ght infections.
  • Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc.

Orchid Pharma Ltd News Hub

News

Orchid Pharma consolidated net profit rises 212.23% in the June 2024 quarter

Net profit of Orchid Pharma rose 212.23% to Rs 29.35 crore in the quarter ended June 2024 ...

Read more

2024-08-13 00:00:00

News

Orchid Pharma announces board meeting date

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 20...

Read more

2024-08-10 00:00:00

News

Orchid Pharma to hold board meeting

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November ...

Read more

2024-11-06 00:00:00

News

Orchid Pharma consolidated net profit rises 37.58% in the September 2024 quarter

Net profit of Orchid Pharma rose 37.58% to Rs 27.24 crore in the quarter ended September 2...

Read more

2024-11-11 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Orchid Pharma Ltd

What is the current PE Ratio of Orchid Pharma Ltd?

The Current PE Ratio of Orchid Pharma Ltd is 73.5 as on 11 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Dec 2024.

What was the PE Ratio of Orchid Pharma Ltd last year?

The PE Ratio of Orchid Pharma Ltd was 33.87 last year, now the PE ratio is 73.5, showing a year-on-year growth of 117.0%.

What does the PE Ratio of Orchid Pharma Ltd indicate about its stock?

The PE Ratio of Orchid Pharma Ltd is 73.5. This ratio indicates that investors are willing to pay 73.5 times the earnings per share for each share of Orchid Pharma Ltd.

What is the PE Ratio Growth of Orchid Pharma Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Orchid Pharma Ltd grew by 117.0% whereas, the EPS ratio grew by -7.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions